Free Trial

Revvity (RVTY) Competitors

Revvity logo
$118.29 -1.24 (-1.04%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RVTY vs. KEYS, FTV, VLTO, TER, AVTR, BIO.B, NVMI, VNT, ST, and CAMT

Should you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Keysight Technologies (KEYS), Fortive (FTV), Veralto (VLTO), Teradyne (TER), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Sensata Technologies (ST), and Camtek (CAMT). These companies are all part of the "measuring and control equipment" industry.

Revvity vs.

Keysight Technologies (NYSE:KEYS) and Revvity (NYSE:RVTY) are both large-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, community ranking, analyst recommendations, institutional ownership and risk.

In the previous week, Keysight Technologies had 6 more articles in the media than Revvity. MarketBeat recorded 20 mentions for Keysight Technologies and 14 mentions for Revvity. Keysight Technologies' average media sentiment score of 1.07 beat Revvity's score of 0.59 indicating that Keysight Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Keysight Technologies
10 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Revvity
7 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

84.6% of Keysight Technologies shares are held by institutional investors. Comparatively, 86.7% of Revvity shares are held by institutional investors. 0.6% of Keysight Technologies shares are held by company insiders. Comparatively, 0.6% of Revvity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Revvity has lower revenue, but higher earnings than Keysight Technologies. Keysight Technologies is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Keysight Technologies$4.98B5.76$614M$3.5047.34
Revvity$2.75B5.23$693.09M$2.0757.15

Keysight Technologies has a net margin of 12.32% compared to Revvity's net margin of 9.34%. Keysight Technologies' return on equity of 19.22% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Keysight Technologies12.32% 19.22% 10.52%
Revvity 9.34%7.42%4.40%

Keysight Technologies has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Revvity has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500.

Keysight Technologies presently has a consensus price target of $180.80, suggesting a potential upside of 9.11%. Revvity has a consensus price target of $132.46, suggesting a potential upside of 11.98%. Given Revvity's higher probable upside, analysts plainly believe Revvity is more favorable than Keysight Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Keysight Technologies
1 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.80
Revvity
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.71

Keysight Technologies received 448 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 65.97% of users gave Keysight Technologies an outperform vote while only 58.14% of users gave Revvity an outperform vote.

CompanyUnderperformOutperform
Keysight TechnologiesOutperform Votes
473
65.97%
Underperform Votes
244
34.03%
RevvityOutperform Votes
25
58.14%
Underperform Votes
18
41.86%

Summary

Keysight Technologies beats Revvity on 12 of the 18 factors compared between the two stocks.

Get Revvity News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVTY vs. The Competition

MetricRevvityAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$13.86B$5.83B$5.26B$19.43B
Dividend Yield0.25%0.43%5.11%3.71%
P/E Ratio57.159.9857.4134.03
Price / Sales5.234.121,268.3917.14
Price / Cash13.7944.7543.7519.84
Price / Book1.852.395.315.76
Net Income$693.09M$2.94M$122.62M$993.25M
7 Day Performance-3.64%-1.43%0.65%3.12%
1 Month Performance5.09%1.62%2.61%4.75%
1 Year Performance11.15%-20.91%25.82%18.83%

Revvity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVTY
Revvity
3.783 of 5 stars
$118.29
-1.0%
$132.46
+12.0%
+11.1%$14.40B$2.75B57.1511,500Ex-Dividend
Gap Up
KEYS
Keysight Technologies
4.6148 of 5 stars
$161.16
-0.1%
$180.80
+12.2%
+7.9%$27.91B$4.98B46.0514,900Short Interest ↓
Analyst Revision
FTV
Fortive
4.5647 of 5 stars
$76.14
+1.1%
$86.64
+13.8%
+9.3%$26.42B$6.20B30.3318,000Analyst Downgrade
VLTO
Veralto
2.8731 of 5 stars
$101.13
+1.0%
$113.27
+12.0%
+32.8%$25.01B$5.14B31.2116,000
TER
Teradyne
4.7233 of 5 stars
$133.16
-0.8%
$150.33
+12.9%
+27.3%$21.69B$2.74B42.276,500
AVTR
Avantor
4.0619 of 5 stars
$22.10
+2.0%
$27.69
+25.3%
+2.6%$15.04B$6.82B48.0414,500Analyst Forecast
Short Interest ↑
News Coverage
High Trading Volume
BIO.B
Bio-Rad Laboratories
N/A$341.00
flat
N/AN/A$9.55B$2.58B-12.488,200
NVMI
Nova
1.8447 of 5 stars
$217.85
+0.1%
$238.33
+9.4%
+69.6%$6.33B$611.85M40.643,606
VNT
Vontier
4.0262 of 5 stars
$35.75
-0.6%
$44.63
+24.8%
+6.2%$5.37B$2.99B13.708,000
ST
Sensata Technologies
4.7182 of 5 stars
$27.44
+0.7%
$41.00
+49.4%
-17.5%$4.10B$4.02B-50.8120,800Analyst Forecast
News Coverage
Positive News
CAMT
Camtek
3.6912 of 5 stars
$86.79
-3.0%
$110.78
+27.6%
+31.6%$3.94B$400.63M40.00400Analyst Forecast
Short Interest ↑
Gap Up

Related Companies and Tools


This page (NYSE:RVTY) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners